ABT - Abbott Laboratories

NYSE * Health Care * Health Care Equipment & Supplies

$116.35

+$0.09 (+0.08%)

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

ABT Key Statistics

Market Cap

$202.50B

P/E Ratio

31.28

P/B Ratio

3.97

EPS

$3.72

Dividend Yield

0.02%

Revenue Growth

+0.0%

Profit Margin

0.1%

Employees

115,000

How ABT Compares to Peers

ABT trades at a premium valuation vs peers (highest P/E)
ABT has the highest profit margins in Health Care Equipment & Supplies
ABT is the smallest among peers, which may offer higher growth potential

P/E Rank

#2

of 2

Margin Rank

#1

of 2

Growth Rank

#2

of 2

Size Rank

#2

of 2

CompanyP/EGrowthCompare
ABT31.30%-
AMZN29.30%vs AMZN

Abbott Laboratories Company Information

Headquarters
Illinois; U.S.A
Website
www.abbott.com
Sector
Health Care
Industry
Health Care Equipment & Supplies
Data Updated:
Ready to invest in ABT?

Commission-free trading available. Affiliate links.

ABT Lician Score

14% confidence
5.0/10
Neutral

ABT has a Lician Score of 5/10 (Average). The stock shows average characteristics across all dimensions.

value

5.0

growth

6.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates ABTacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

ABT Financial Snowflake

5-axis analysis across key investment dimensions

5.2/10

Neutral

35810Value5.0Growth6.0Quality5.0Momentum5.0Safety5.05.2/10
5.0

Value

6.0

Growth

5.0

Quality

5.0

Momentum

5.0

Safety

Upcoming Events for ABT